| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q6IP81 | Leukotriene A(4) hydrolase; LTA-4 hydrolase; EC 3.3.2.6; | lta4h; MGC78867; | NP_001085236.1; | 609 | clawed frog |
| Q7LZ38 | Beta-crystallin; Fragment; | NULL | NULL | 53 | clawed frog |
| Q6NRR9 | LOC431982 protein; Fragment; | LOC431982; | NULL | 195 | clawed frog |
| Q7T3S1 | PP2A B'' subunit PR48; | ppp2r3b; | NP_001082625.1; | 565 | clawed frog |
| Q7ZXN8 | Rbp4-prov protein; | NULL | NP_001080467.1; | 197 | clawed frog |
| Q5U4T4 | LOC495438 protein; | adarb1; LOC495438; | NP_001088561.1; | 699 | clawed frog |
| Q6UDE8 | Pancreas-specific transcription factor 1a; Fragment; | ptf1a; | NULL | 267 | clawed frog |
| Q91885 | RING finger protein; | trim7; | NP_001081456.1; | 528 | clawed frog |
| A1A612 | Uncharacterized protein; Fragment; | NULL | NULL | 363 | clawed frog |
| Q7T226 | Velo1; | velo1; | NP_001082685.1; | 779 | clawed frog |
| A1L2L9 | LOC100036888 protein; | sgpp2; LOC100036888; | NP_001091137.1; | 400 | clawed frog |
| A1L2G8 | LOC443651 protein; | spryd3; LOC443651; | NP_001085291.1; | 397 | clawed frog |
| A2VD02 | LOC100037169 protein; | prpf4b; LOC100037169; | NP_001091334.1; | 959 | clawed frog |
| A2RV98 | LOC446933 protein; Fragment; | LOC446933; | NULL | 291 | clawed frog |
| A5Y824 | MHC class II antigen beta chain; Fragment; | NULL | NULL | 52 | clawed frog |
| Q7ZXR1 | MGC53888 protein; | kiaa0247; | NP_001079558.1; | 300 | clawed frog |
| Q9I8B6 | Olfactory receptor; | or1s1; xb352; | NP_001081908.1; | 314 | clawed frog |
| A4FVD3 | LOC100049125 protein; | LOC100049125; | NP_001091427.1; | 130 | clawed frog |
| U5NTR6 | NumbL; | NULL | NULL | 608 | clawed frog |
| Q804T2 | Ser/Thr protein kinase PAR-1A; | mark3; | NP_001084256.1; | 725 | clawed frog |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |